You are here

  • Home
  • Archive
  • Volume 19, Issue 5
  • Phase II Study of Intraperitoneal Carboplatin With Intravenous Paclitaxel in Patients With Suboptimal Residual Epithelial Ovarian or Primary Peritoneal Cancer: A Sankai Gynecology Cancer Study Group Study

Citation Tools

Article menu
Download PDFPDF
Ovarian Cancer
Phase II Study of Intraperitoneal Carboplatin With Intravenous Paclitaxel in Patients With Suboptimal Residual Epithelial Ovarian or Primary Peritoneal Cancer: A Sankai Gynecology Cancer Study Group Study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Fujiwara K, Nagao S, Kigawa J, et al
Phase II Study of Intraperitoneal Carboplatin With Intravenous Paclitaxel in Patients With Suboptimal Residual Epithelial Ovarian or Primary Peritoneal Cancer: A Sankai Gynecology Cancer Study Group Study
International Journal of Gynecologic Cancer 2009;19:834-837.